PPARG and pulmonary fibrosis: The inhibition of the TGF-β/Smad pathway via PPARγ activation mediates the suppression of fibroblast-to-myofibroblast transdifferentiation, which underlies the anti-pulmonary fibrosis effects of lathyrol.